SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
We previously described a new form of recessive ataxia, Salih ataxia, in a large consanguineous Saudi Arabian family with three affected children carrying a new identified mutation in the KIAA0226 gene (c.2624delC; p.Ala875ValfsX146) coding for Rubicon.
|
23728897 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Rundataxin, a novel protein with RUN and diacylglycerol binding domains, is mutant in a new recessive ataxia.
|
20826435 |
2010 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Rundataxin, a novel protein with RUN and diacylglycerol binding domains, is mutant in a new recessive ataxia.
|
20826435 |
2010 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Ataxia, Spinocerebellar
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 2
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 4
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 5
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 6 (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 7
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lupus Erythematosus, Systemic
|
0.210 |
Biomarker
|
disease |
BEFREE |
Abbreviations: ALB: albumin; ARHGDIB: Rho GDP dissociation inhibitor beta; APOL1: apolipoprotein L1; ATG5: autophagy related 5; ATG7: autophagy related 7; ATG16L2: autophagy related 16 like 2; BECN1: beclin 1; CDKN1B: cyclin dependent kinase inhibitor 1B; CLEC16A, C-type lectin domain containing 16A; CYBB: cytochrome b-245 beta chain; DC: dendritic cell; DRAM1: DNA damage regulated autophagy modulator 1; eQTL: expression quantitative trait loci; GWAS: genome-wide association study; IFNA: interferon alpha; IRGM: immunity related GTPase M; LRRK2: leucine rich repeat kinase 2; MAP1LC3B: microtubule associated protein 1 light chain 3 beta; MTMR3: myotubularin related protein 3; LAP" LC3-associated phagocytosis; LN: lupus nephritis; NOD: non-obese diabetic; NPHS2: NPHS2, podocin; PBMC: peripheral blood mononuclear cell; RUBCN: rubicon autophagy regulator; SLE: systemic lupus erythematosus.
|
30755075 |
2019 |
Lupus Erythematosus, Systemic
|
0.210 |
Biomarker
|
disease |
MGD |
Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells.
|
27096368 |
2016 |
Ataxia
|
0.110 |
Biomarker
|
phenotype |
BEFREE |
The rundataxin pathway appears therefore distinct from the ataxia pathways involving deficiency in mitochondrial or nuclear proteins and broadens the range of mechanisms leading to recessive ataxias.
|
20826435 |
2010 |
Ataxia
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Nystagmus
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyporeflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperreflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait, Unsteady
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Flexion contracture - elbow
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Delayed speech and language development
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|